Tom Tice,Gary Winchester,Kevin Burton,Michael J. Jozwiakowski,Robert Birch,Kyle Haraldsen,Jeff Caplette
申请号：
US16301237
公开号：
US20190282588A1
申请日:
2017.05.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The disclosure is directed in part to extended release compositions that include hydroxy progesterone caproate. For example, provided herein is a therapeutic microparticle composition comprising a plurality of microparticles, wherein the microparticles each comprise poly (lactide-co-glycolide) and hydroxyprogesterone caproate.
